Health policy, public affairs and regulatory consulting
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2024 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$15,000 | — | |
| 2024 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$15,000 | — | |
| 2024 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$15,000 | — | |
| 2024 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$15,000 | — | |
| 2024 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$15,000 | — | |
| 2023 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$15,000 | — | |
| 2023 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$15,000 | — | |
| 2023 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$15,000 | — | |
| 2023 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$15,000 | — | |
| 2022 | ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$15,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) | 74 | $1,250,000 |
| ALLERGAN | 8 | $50,000 |
| RARE DISEASE THERAPEUTICS | 6 | $25,000 |
| Name | Disclosed Prior Position |
|---|---|
| STEVEN GROSSMAN | N/A |
| GEOFFREY PETERSON |